Tag: electroceutical

2 articles

Market Moves

Korea's Ybrain electroceutical startup restarts its stalled KOSDAQ IPO

Korean depression-tDCS device maker Ybrain has restarted its KOSDAQ IPO process in 2026, with Ceragem holding a 41.19 percent stake and NH Investment & Securities as lead bookrunner. Listing is targeted for early 2027.

Jun 28

Industry News

Three patients received a 30-minute test of Coherence Neuro's brain-tumor implant at Royal Melbourne Hospital

Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.

Jun 23

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.